Track: Neuroimaging and Brain Mapping

Neuropsychiatry 2025

The "Neuroimaging and Brain Mapping" track explores the latest advancements in imaging technologies and their application in understanding brain structure, function, and disorders. This session covers cutting-edge techniques that allow researchers and clinicians to visualize the brain in unprecedented detail, helping to improve diagnosis, treatment planning, and outcomes for neurological and psychiatric conditions. Participants will gain insights into the latest neuroimaging modalities, including functional MRI, PET, and advanced brain mapping techniques.

Advances in Functional MRI (fMRI) and Applications: 
This session delves into the advancements in functional magnetic resonance imaging (fMRI), a powerful tool for mapping brain activity. The discussion will focus on the application of fMRI in understanding neural networks, brain plasticity, and its role in assessing neurological and psychiatric conditions such as stroke, epilepsy, and schizophrenia.

Diffusion Tensor Imaging (DTI) and White Matter Mapping: 
Explore the use of Diffusion Tensor Imaging (DTI) in mapping the brain’s white matter tracts. This advanced neuroimaging technique provides insights into brain connectivity, helping clinicians study disorders like multiple sclerosis, Alzheimer's disease, and traumatic brain injuries. Attendees will learn about the latest DTI innovations and their clinical relevance.

Positron Emission Tomography (PET) in Brain Imaging: 
This topic highlights the role of Positron Emission Tomography (PET) in studying brain metabolism, neuroreceptor activity, and protein deposition. The session will focus on its use in diagnosing and monitoring conditions like Alzheimer's, Parkinson's, and brain tumors, with a focus on new PET tracers and their diagnostic applications.

Brain Mapping and Functional Connectivity: 
This session will explore advances in brain mapping techniques used to understand functional connectivity and brain networks. Topics will include resting-state fMRI, network analysis, and how these approaches are being used to study cognitive functions, neurodevelopmental processes, and brain disorders such as autism and ADHD.

Magnetoencephalography (MEG) and Electroencephalography (EEG) in Brain Mapping: 
This topic will focus on the use of MEG and EEG in real-time brain activity mapping. These non-invasive methods provide temporal resolution for studying neural oscillations, event-related potentials, and brain networks, especially in the context of epilepsy, neurodegeneration, and sensory processing disorders.

Neuroimaging in Psychiatric Disorders:
This session examines the role of neuroimaging in understanding the pathophysiology of psychiatric conditions such as depression, schizophrenia, and bipolar disorder. Advances in brain mapping are providing a clearer understanding of brain abnormalities, functional disruptions, and potential treatment targets.

Brain-Computer Interfaces (BCIs) and Neuroimaging: 
Brain-Computer Interfaces (BCIs) represent a frontier in both brain mapping and rehabilitation. This topic explores the integration of neuroimaging with BCIs, discussing how these systems are being used for cognitive enhancement, motor recovery after stroke, and communication in patients with severe neurological impairments.

This track aims to bring together researchers, clinicians, and technologists to discuss the transformative power of neuroimaging in understanding the brain’s structure and function. It provides a comprehensive overview of how modern imaging techniques are revolutionizing neuroscience and clinical practice in neurology and psychiatry.